BDTX
USDBlack Diamond Therapeutics Inc. Common Stock
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$2.350
Máximo
$2.380
Mínimo
$2.300
Volumen
0.56M
Fundamentos de la Empresa
Capitalización de Mercado
135.0M
Industria
Biotecnología
País
United States
Estadísticas de Negociación
Volumen Promedio
3.50M
Bolsa
NMS
Moneda
USD
Rango de 52 Semanas
Noticias Relacionadas
Servier and Black Diamond Therapeutics Announce Global Licensing Agreement for BDTX-4933, A Targeted Oncology Therapy
The partnership underscores Servier's commitment to developing targeted therapies that address unmet medical needs in oncologyServier will develop and commercialize BDTX-4933, a Phase 1 asset with best-in-class potential
HC Wainwright & Co. Maintains Buy on Black Diamond Therapeutic, Raises Price Target to $12
HC Wainwright & Co. analyst Robert Burns maintains Black Diamond Therapeutic with a Buy and raises the price target from $11 to $12.
Stifel Maintains Buy on Black Diamond Therapeutic, Lowers Price Target to $15
Stifel analyst Bradley Canino maintains Black Diamond Therapeutic with a Buy and lowers the price target from $16 to $15.
Acciones Relacionadas
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.